Cargando…
Real-world experience of using ciclosporin-A 0.1% in the management of ocular surface inflammatory diseases
PURPOSE: To report the real-world experience of using topical ciclosporin, Ikervis, in the management of ocular surface inflammatory diseases (OSIDs). METHODS: This was a retrospective study of patients treated with Ikervis for OSIDs at the Queen’s Medical Centre, Nottingham, between 2016 and 2019....
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340021/ https://www.ncbi.nlm.nih.gov/pubmed/33687999 http://dx.doi.org/10.1136/bjophthalmol-2020-317907 |